BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2582711)

  • 1. Pharmacodynamics of intravenous ranitidine after bolus and continuous infusion in patients with healed duodenal ulcers.
    Sanders SW; Buchi KN; Moore JG; Bishop AL
    Clin Pharmacol Ther; 1989 Nov; 46(5):545-51. PubMed ID: 2582711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bolus or intravenous infusion of ranitidine: effects on gastric pH and acid secretion. A comparison of relative efficacy and cost.
    Ballesteros MA; Hogan DL; Koss MA; Isenberg JI
    Ann Intern Med; 1990 Mar; 112(5):334-9. PubMed ID: 2306061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of intravenous infusion of omeprazole and ranitidine on twenty-four-hour intragastric pH in patients with a history of duodenal ulcer.
    Kiilerich S; Rannem T; Elsborg L
    Digestion; 1995; 56(1):25-30. PubMed ID: 7895928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intragastric pH and pharmacokinetics of intravenous ranitidine during sinusoidal and constant-rate infusions.
    Sanders SW; Bishop AL; Moore JG
    Chronobiol Int; 1991; 8(4):267-76. PubMed ID: 1797416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of gastric pH with ranitidine in critically ill patients. Comparison of two intravenous regimens.
    Santucci L; Fiorucci S; Pelli MA; Calderazzo A; Biasini E; Calderazzo PL; Morelli A
    Dig Dis Sci; 1991 May; 36(5):583-7. PubMed ID: 2022159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of intravenous infusion of ranitidine on intragastric acidity in fasting subjects: comparison with bolus or Gastrojet (pH-stat-adjusted) infusion.
    Thomson AB; Kirdeikis P; Simon K; Zuk L; Pinchbeck B; Wasarab-Rolland D; Kersey K
    Aliment Pharmacol Ther; 1993 Dec; 7(6):649-53. PubMed ID: 8161672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of two dosing regimens of intravenous ranitidine on gastric pH in critically ill children.
    Osteyee JL; Banner W
    Am J Crit Care; 1994 Jul; 3(4):267-72. PubMed ID: 7920954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and pharmacodynamics of ranitidine in critically ill children.
    Lugo RA; Harrison AM; Cash J; Sweeley J; Vernon DD
    Crit Care Med; 2001 Apr; 29(4):759-64. PubMed ID: 11373465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous cimetidine or two regimens of ranitidine to reduce fasting gastric acidity.
    Peterson WL; Richardson CT
    Ann Intern Med; 1986 Apr; 104(4):505-7. PubMed ID: 3954278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastric acid suppression is greater during intravenous ranitidine infusion versus bolus injections of famotidine.
    Hogan DL; McQuaid KR; Koss MA; Crombie DL; Hunter S; Metz C; Euler AR; Isenberg JI
    Aliment Pharmacol Ther; 1993 Oct; 7(5):537-41. PubMed ID: 8280822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of repeated injection and continuous infusion of omeprazole and ranitidine on intragastric pH over 72 hours.
    Netzer P; Gaia C; Sandoz M; Huluk T; Gut A; Halter F; Hüsler J; Inauen W
    Am J Gastroenterol; 1999 Feb; 94(2):351-7. PubMed ID: 10022628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Day-night and individual differences in response to constant-rate ranitidine infusion.
    White C; Smolensky MH; Sanders SW; Buchi KN; Moore JG
    Chronobiol Int; 1991 Feb; 8(1):56-66. PubMed ID: 1814603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ranitidine in the treatment of duodenal ulcer disease: relationship between antisecretory effect and ulcer healing rate.
    McIsaac RL; Dixon JS; Mills JG; Wood JR
    Aliment Pharmacol Ther; 1991 Jun; 5(3):227-43. PubMed ID: 1888823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of two ranitidine intravenous infusion regimens in critically ill patients.
    Marchant J; Summers K; McIsaac RL; Wood JR
    Aliment Pharmacol Ther; 1988 Feb; 2(1):55-63. PubMed ID: 2979234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of basal gastric acid secretion on the pharmacodynamics of ranitidine.
    Sanders SW; Ballersteros MA; Hogan DL; Koss MA; Isenberg JI
    Chronobiol Int; 1991; 8(3):186-93. PubMed ID: 1794156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A controlled comparison of continuous ranitidine and intermittent famotidine infusions on gastric pH.
    Bachmann K; Sullivan TJ; Jauregui L
    J Clin Pharmacol; 1993 Dec; 33(12):1219-24. PubMed ID: 7907348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of bedtime ranitidine on overnight gastric acid output and intragastric pH: dose/response study and comparison with cimetidine.
    Chambers JB; Pryce D; Bland JM; Northfield TC
    Gut; 1987 Mar; 28(3):294-9. PubMed ID: 3570035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacodynamics of bolus famotidine versus infused cimetidine, ranitidine, and famotidine.
    Amsden GW; Goss TF; Harrison NJ; D'Andrea DT; Schentag JJ
    J Clin Pharmacol; 1994 Dec; 34(12):1191-8. PubMed ID: 7738215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of the timing of administration of 300 mg ranitidine on 24-hour gastric pH in patients acute duodenal ulcer.
    Cortot A; Guillemot F; Moreau J; Soule JC; Veyrac M; Alberola B; Pappo M
    Aliment Pharmacol Ther; 1992 Aug; 6(4):487-93. PubMed ID: 1420740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Does nocturnal monitoring of gastric pH permit the prediction of therapeutic response in severe duodenal ulcer treated with ranitidine?].
    Galmiche JP; Tranvouez JL; Denis P; N'Djitoyap C; Guillard JF; Lehur PA; Colin R
    Gastroenterol Clin Biol; 1985; 9(8-9):583-9. PubMed ID: 4076717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.